STOCK TITAN

Olink to participate in November investor events

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) announced participation in two upcoming investor events. The Olink Investor Day 2022 is scheduled for November 14 at 11:00 am ET, followed by the Canaccord Genuity MedTech Forum on November 17 at 2:00 pm ET. A live and archived webcast of the Investor Day will be accessible on Olink's website. Founded in 2016 and headquartered in Uppsala, Sweden, Olink focuses on advancing proteomics to enable scientific discoveries and improve patient outcomes.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OLK

-0.60%
-0.60% Session move

In the trading session that priced this news, OLK declined 0.60%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UPPSALA, Sweden, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events:

  • Olink Investor Day 2022
    Monday, November 14th at 11:00 am ET
  • Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    Thursday, November 17th at 2:00 pm ET

A live and archived webcast of the Olink Investor Day will be available on the “Events” section of the Company’s website at https://investors.olink.com/news-events/events.

About Olink
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

IR contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com


FAQ